Compounds > n-formylmethionine leucyl-phenylalanine

n-formylmethionine leucyl-phenylalanine and Vascular Diseases

n-formylmethionine leucyl-phenylalanine has been researched along with Vascular Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhondt, A; Glorieux, G; Leybaert, L; Schepers, E; Vanholder, R1
Davies, JE; Jennings, SC; Ng, LL; Pettit, AI; Quinn, PA; Wong, RK1
Capecchi, PL; Ceccatelli, L; Di Perri, T; Laghi Pasini, F; Orrico, A; Pasqui, AL1
Fantone, JC; Kunkel, SL; Ward, PA1
Caimi, G; Canino, B; Catania, A; Ferrara, F; Lo Presti, R; Meli, F; Montana, M; Ventimiglia, G1

Other Studies

5 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Vascular Diseases

ArticleYear
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Arginine; Calcium; Calcium Channel Blockers; Calcium Channels; Captopril; Edetic Acid; Enzyme Inhibitors; Humans; Imidazoles; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Reactive Oxygen Species; Respiratory Burst; Thapsigargin; Vascular Diseases

2009
Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid.
    Circulation, 2003, Oct-14, Volume: 108, Issue:15

    Topics: Acetylcysteine; Adult; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Enzyme Inhibitors; Glycation End Products, Advanced; Group IV Phospholipases A2; Humans; Indomethacin; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Organophosphonates; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Quinacrine; Reactive Oxygen Species; Respiratory Burst; Vascular Diseases

2003
Heparin inhibition of polymorphonuclear leukocyte activation in vitro. A possible pharmacological approach to granulocyte-mediated vascular damage.
    Thrombosis research, 1984, Sep-01, Volume: 35, Issue:5

    Topics: Cell Aggregation; Enzymes; Granulocytes; Heparin; Humans; In Vitro Techniques; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Superoxides; Vascular Diseases

1984
Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1.
    Prostaglandins and medicine, 1981, Volume: 7, Issue:2

    Topics: Acetylglucosaminidase; Alprostadil; Humans; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Prostaglandins E; Vascular Diseases

1981
Type II diabetics with macrovascular complications: polymorphonuclear leukocyte (PMN) filtration, PMN membrane fluidity and cytosolic Ca2+ content after activation.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1998, Volume: 30, Issue:2

    Topics: Aged; Calcium; Cell Movement; Cytosol; Diabetes Mellitus, Type 2; Diphenylhexatriene; Fluorescence Polarization; Fluorescent Dyes; Fura-2; Humans; Membrane Fluidity; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Tetradecanoylphorbol Acetate; Vascular Diseases

1998